BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2986619)

  • 1. Studies on four cellular proto-oncogenes and their expression in PCC4 embryonal carcinoma cells: amplification of c-Ki-ras oncogene.
    Vilette D; Emanoil-Ravier R; Tobaly J; Peries J
    Biochem Biophys Res Commun; 1985 Apr; 128(2):513-9. PubMed ID: 2986619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-Ki-ras gene amplification and malignant behavior in murine embryonal carcinoma cell lines.
    Vilette D; Emanoil-Ravier R; Buffe D; Rimbaut C; Peries J
    Cancer Res; 1987 Feb; 47(3):867-73. PubMed ID: 3542196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amplification and rearrangement of Ki-ras oncogene in human teratocarcinoma-derived cell lines.
    Tobaly-Tapiero J; Saal F; Peries J; Emanoil-Ravier R
    Biochimie; 1986; 68(7-8):1019-23. PubMed ID: 3017457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of cellular oncogenes in teratoma-derived cell lines.
    Sejersen T; Sümegi J; Ringertz NR
    Exp Cell Res; 1985 Sep; 160(1):19-30. PubMed ID: 2412863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amplification and expression of protooncogenes in human small cell lung cancer cell lines.
    Kiefer PE; Bepler G; Kubasch M; Havemann K
    Cancer Res; 1987 Dec; 47(23):6236-42. PubMed ID: 2824028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro growth properties and PCR ras gene analysis of a murine embryonal carcinoma cell line harboring an amplified c-Ki-ras gene.
    Vilette D; d'Auriol L; Galibert F; Peries J; Emanoil-Ravier R
    Biol Cell; 1989; 65(3):215-9. PubMed ID: 2665885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amplification of c-Ki-ras gene and aberrant expression of c-myc in WI-38 cells transformed in vitro by gamma-irradiation.
    Mizuki K; Nose K; Okamoto H; Tsuchida N; Hayashi K
    Biochem Biophys Res Commun; 1985 Apr; 128(2):1037-43. PubMed ID: 2581563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amplification of the c-myc oncogene in human plasma-cell leukemia.
    Sümegi J; Hedberg T; Björkholm M; Godal T; Mellstedt H; Nilsson MG; Perlman C; Klein G
    Int J Cancer; 1985 Sep; 36(3):367-71. PubMed ID: 2863225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular oncogenes in human teratocarcinoma cell lines.
    Tesch H; Fürbass R; Casper J; Lyons J; Bartram CR; Schmoll HJ; Bronson DL
    Int J Androl; 1990 Oct; 13(5):377-88. PubMed ID: 2283183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amplification of the c-myc oncogene in one of five human breast carcinoma cell lines.
    Kozbor D; Croce CM
    Cancer Res; 1984 Feb; 44(2):438-41. PubMed ID: 6692352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of cellular oncogenes during rat liver development.
    Zhang XK; Wang Z; Lee A; Huang DP; Chiu JF
    Cancer Lett; 1988 Aug; 41(2):147-55. PubMed ID: 2456853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of c-myc gene in human hepatoma.
    Su TS; Lin LH; Lui WY; Chang CM; Chou CK; Ting LP; Hu CP; Han SH; P'eng FK
    Biochem Biophys Res Commun; 1985 Oct; 132(1):264-8. PubMed ID: 2415125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Activation of ras and myc proto-oncogenes in human breast carcinoma and neuroblastoma].
    Kniazev PG; Schafer R; Willecke K; Pluzhnikova GF; Serova OM
    Mol Biol (Mosk); 1986; 20(5):1236-43. PubMed ID: 3022123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced expression of c-myc and decreased expression of c-fos protooncogenes in chemically and radiation-transformed C3H/10T1/2 Cl 8 mouse embryo cell lines.
    Shuin T; Billings PC; Lillehaug JR; Patierno SR; Roy-Burman P; Landolph JR
    Cancer Res; 1986 Oct; 46(10):5302-11. PubMed ID: 2875790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cellular oncogene (c-Ki-ras) is amplified, overexpressed, and located within karyotypic abnormalities in mouse adrenocortical tumour cells.
    Schwab M; Alitalo K; Varmus HE; Bishop JM; George D
    Nature; 1983 Jun 9-15; 303(5917):497-501. PubMed ID: 6304530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of N-myc, c-myc and c-src proto-oncogenes during the course of induced differentiation of murine embryonal carcinoma cells.
    Sumegi J; Sejersen T; Björklund H; Klein G; Ringertz NR
    Curr Top Microbiol Immunol; 1986; 132():297-304. PubMed ID: 2431836
    [No Abstract]   [Full Text] [Related]  

  • 17. Expression of N-myc in teratocarcinoma stem cells and mouse embryos.
    Jakobovits A; Schwab M; Bishop JM; Martin GR
    Nature; 1985 Nov 14-20; 318(6042):188-91. PubMed ID: 3840574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of cellular oncogene rearrangement or amplification in ovarian adenocarcinomas.
    Smith DM; Groff DE; Pokul RK; Bear JL; Delgado G
    Am J Obstet Gynecol; 1989 Oct; 161(4):911-5. PubMed ID: 2801838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of c-Ha-ras and c-Ki-ras gene expression in rat mammary gland.
    Nieto A; Qasba PK; Nakhasi HL; Dhar R
    Carcinogenesis; 1987 Dec; 8(12):1955-8. PubMed ID: 2824087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of c-mos proto-oncogene in undifferentiated teratocarcinoma cells.
    Ogiso Y; Matsumoto M; Morita T; Nishino H; Iwashima A; Matsushiro A
    Biochem Biophys Res Commun; 1986 Oct; 140(2):477-84. PubMed ID: 3778463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.